AU2002257859A1 - Use of alverine or one of its salts - Google Patents

Use of alverine or one of its salts

Info

Publication number
AU2002257859A1
AU2002257859A1 AU2002257859A AU2002257859A AU2002257859A1 AU 2002257859 A1 AU2002257859 A1 AU 2002257859A1 AU 2002257859 A AU2002257859 A AU 2002257859A AU 2002257859 A AU2002257859 A AU 2002257859A AU 2002257859 A1 AU2002257859 A1 AU 2002257859A1
Authority
AU
Australia
Prior art keywords
alverine
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002257859A
Inventor
Lionel Breton
Christel Liviero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of AU2002257859A1 publication Critical patent/AU2002257859A1/en
Abandoned legal-status Critical Current

Links

AU2002257859A 2001-04-09 2002-04-09 Use of alverine or one of its salts Abandoned AU2002257859A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR01/04810 2001-04-09

Publications (1)

Publication Number Publication Date
AU2002257859A1 true AU2002257859A1 (en) 2002-10-21

Family

ID=

Similar Documents

Publication Publication Date Title
HK1208446A1 (en) Derivatives of uk-2a uk-2a
AU2002256418A1 (en) Inhibitors of bace
AU2002351749A1 (en) Salt coatings
PT1445249E (en) Novel bensophenone derivatives or salts thereof
AU2002330453A1 (en) Crystals of hydroxynorephedrine derivative
AU2002238103A1 (en) Use of beta-lactamase inhibitors as neuroprotectants
AUPR566701A0 (en) Electrolytic activation of fluids
AU2002306734A1 (en) Inhibitors of plasmepsins
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2002304626A1 (en) Sterilization of surfaces
HUP0401641A3 (en) Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors
AU2002337601A1 (en) Process for the preparation of simvastatin
AU2002257859A1 (en) Use of alverine or one of its salts
AU2002305868A1 (en) Inhibitors of reggamma
AU2002340237A1 (en) Methods of inhibiting osteoclast activity
EP1238585B8 (en) Use of esterquats
AU2002366756A1 (en) Use of benzofuroxan derivatives as antiplatelet agents
AU2002304733A1 (en) Amino-aza-cyclohexanes for the treatment of malaria
AU2002255261A1 (en) Novel use of arylethenessulfonamide derivatives
AU2002345602A1 (en) Crystalline salts of benzoylbenzofuran-derivatives
AU2002359898A1 (en) Preparation of alpha-diimines
AU2002247289A1 (en) Human grk7: new member of the human g-protein-coupled-receptor kinase family
AU2002230110A1 (en) 2-acylaminothiazole derivative or its salt
AU2002350507A1 (en) Use of cystathionine
AU2002350560A1 (en) Silver salts of sucrose-octasulphate